• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高催乳素血症的诊断与管理

Diagnosis and management of hyperprolactinemia.

作者信息

Serri Omar, Chik Constance L, Ur Ehud, Ezzat Shereen

机构信息

Division of Endocrinology, University of Montréal, Montréal, Que.

出版信息

CMAJ. 2003 Sep 16;169(6):575-81.

PMID:12975226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC191295/
Abstract

Prolactin is a pituitary hormone that plays a pivotal role in a variety of reproductive functions. Hyperprolactinemia is a common condition that can result from a number of causes, including medication use and hypothyroidism as well as pituitary disorders. Depending on the cause and consequences of the hyperprolactinemia, selected patients require treatment. The underlying cause, sex, age and reproductive status must be considered. We describe the diagnostic approach and management of hyperprolactinemia in various clinical settings, with emphasis on newer diagnostic strategies and the role of various therapeutic options, including treatment with selective dopamine agonists.

摘要

催乳素是一种垂体激素,在多种生殖功能中起关键作用。高催乳素血症是一种常见病症,可由多种原因引起,包括药物使用、甲状腺功能减退以及垂体疾病。根据高催乳素血症的病因和后果,部分患者需要接受治疗。必须考虑潜在病因、性别、年龄和生殖状态。我们描述了在各种临床情况下高催乳素血症的诊断方法和管理,重点介绍了更新的诊断策略以及各种治疗选择的作用,包括使用选择性多巴胺激动剂进行治疗。

相似文献

1
Diagnosis and management of hyperprolactinemia.高催乳素血症的诊断与管理
CMAJ. 2003 Sep 16;169(6):575-81.
2
[The diagnosis of hyperprolactinemia in clinical practice].
Ginekol Pol. 2005 Dec;76(12):1008-13.
3
Hyperprolactinemia. Evaluation and management.
Endocrinol Metab Clin North Am. 1992 Mar;21(1):105-24.
4
Hyperprolactinemia and prolactinomas.高催乳素血症与催乳素瘤
Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii. doi: 10.1016/j.ecl.2007.10.013.
5
Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.高催乳素血症的医学病因及后果。精神科医生的相关背景知识。
J Psychopharmacol. 2008 Mar;22(2 Suppl):28-37. doi: 10.1177/0269881107087951.
6
Pituitary imaging is indicated for the evaluation of hyperprolactinemia.垂体成像用于评估高催乳素血症。
Fertil Steril. 2005 Jul;84(1):181-5. doi: 10.1016/j.fertnstert.2005.01.102.
7
Hyperprolactinemia. Causes, consequences, and treatment options.高催乳素血症。病因、后果及治疗选择。
Postgrad Med. 1996 May;99(5):265-8.
8
Medical therapy of hyperprolactinemia.
Endocrinol Metab Clin North Am. 1989 Jun;18(2):259-76.
9
Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence.儿童及青少年高催乳素血症的临床与诊断特征
J Pediatr Endocrinol Metab. 2013;26(1-2):1-11. doi: 10.1515/jpem-2012-0327.
10
Technology insight: measuring prolactin in clinical samples.技术洞察:临床样本中催乳素的检测
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):279-89. doi: 10.1038/ncpendmet0447.

引用本文的文献

1
Successful Pregnancy in Woman With Hyperprolactinemia Associated With Hemorrhagic Giant Craniopharyngioma.患有与出血性巨大颅咽管瘤相关的高泌乳素血症的女性成功怀孕。
Matern Fetal Med. 2025 Apr;7(2):102-104. doi: 10.1097/FM9.0000000000000267. Epub 2025 Feb 11.
2
High-dose Hook Effect in a Case of Giant Prolactinoma Confounded by Acute Kidney Injury.巨大泌乳素瘤合并急性肾损伤病例中的高剂量钩状效应
JCEM Case Rep. 2025 Jun 24;3(8):luaf136. doi: 10.1210/jcemcr/luaf136. eCollection 2025 Aug.
3
Serum Prolactin Levels and Clinical Features of Hyperprolactinaemia in Obese and Non- Obese Infertile Women in Kano, Northwest Nigeria: A Comparative Study.尼日利亚西北部卡诺地区肥胖与非肥胖不孕女性高催乳素血症的血清催乳素水平及临床特征:一项对比研究
Niger Med J. 2024 Nov 6;65(5):749-760. doi: 10.60787/nmj-v65i3.552. eCollection 2024 Sep-Oct.
4
The relationship between low prolactin and type 2 diabetes.低催乳素与2型糖尿病之间的关系。
Rev Endocr Metab Disord. 2024 Dec;25(6):1087-1095. doi: 10.1007/s11154-024-09886-w. Epub 2024 May 18.
5
A Rare Prolactin-secreting Pituitary Carcinoma With Epidural and Thecal Metastases.一例罕见的分泌催乳素垂体癌伴硬膜外和脑脊膜转移
JCEM Case Rep. 2024 Apr 24;2(5):luae047. doi: 10.1210/jcemcr/luae047. eCollection 2024 May.
6
The association between serum prolactin levels and live birth rates in non-PCOS patients: A retrospective cohort study.非 PCOS 患者血清催乳素水平与活产率的关系:一项回顾性队列研究。
PLoS One. 2023 Nov 29;18(11):e0295071. doi: 10.1371/journal.pone.0295071. eCollection 2023.
7
Prolactin Level Changes according to Atypical Antipsychotics Use: A Study Based on Clinical Data Warehouse.根据非典型抗精神病药物使用情况的催乳素水平变化:一项基于临床数据仓库的研究。
Clin Psychopharmacol Neurosci. 2023 Nov 30;21(4):769-777. doi: 10.9758/cpn.23.1057. Epub 2023 Jun 7.
8
The importance of measuring prolactin prior to surgical management of a pituitary lesion: An illustrative case.垂体病变手术治疗前检测催乳素的重要性:一个实例
Radiol Case Rep. 2023 Aug 26;18(11):3889-3893. doi: 10.1016/j.radcr.2023.08.047. eCollection 2023 Nov.
9
Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process.采用ADAPTE流程制定韩国抗精神病药物所致高催乳素血症指南
Clin Psychopharmacol Neurosci. 2023 Aug 31;21(3):447-456. doi: 10.9758/cpn.22.979.
10
Prolactin and oxytocin: potential targets for migraine treatment.催乳素和催产素:偏头痛治疗的潜在靶点。
J Headache Pain. 2023 Mar 27;24(1):31. doi: 10.1186/s10194-023-01557-6.

本文引用的文献

1
The pathogenesis of pituitary tumours.垂体肿瘤的发病机制。
Nat Rev Cancer. 2002 Nov;2(11):836-49. doi: 10.1038/nrc926.
2
Pregnancy outcome after cabergoline treatment in early weeks of gestation.妊娠早期使用卡麦角林治疗后的妊娠结局。
Reprod Toxicol. 2002 Nov-Dec;16(6):791-3. doi: 10.1016/s0890-6238(02)00055-2.
3
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal.催乳素瘤的长期随访:停用溴隐亭后催乳素水平正常
J Clin Endocrinol Metab. 2002 Aug;87(8):3578-82. doi: 10.1210/jcem.87.8.8722.
4
Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas?
Clin Endocrinol (Oxf). 2002 Apr;56(4):562. doi: 10.1046/j.1365-2265.2002.01510.x.
5
Relapse of hyperprolactinemia after transsphenoidal surgery for microprolactinoma: lessons from long-term follow-up.微泌乳素瘤经蝶窦手术后高泌乳素血症复发:长期随访的经验教训
Neurosurgery. 2002 Jan;50(1):36-9; discussion 39-40. doi: 10.1097/00006123-200201000-00007.
6
Macroprolactinemia revisited: a study on 106 patients.再探巨泌乳素血症:一项对106例患者的研究。
J Clin Endocrinol Metab. 2002 Feb;87(2):581-8. doi: 10.1210/jcem.87.2.8272.
7
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.高泌乳素血症中卡麦角林与溴隐亭相比的耐药性:发生率、临床定义及治疗策略
J Clin Endocrinol Metab. 2001 Nov;86(11):5256-61. doi: 10.1210/jcem.86.11.8054.
8
A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients.
J Endocrinol Invest. 2000 Jul-Aug;23(7):428-34. doi: 10.1007/BF03343751.
9
Management of prolactinomas during pregnancy.妊娠期泌乳素瘤的管理
J Reprod Med. 1999 Dec;44(12 Suppl):1121-6.
10
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.高泌乳素血症男性患者对多巴胺激动剂治疗的骨标志物和骨密度反应。
J Clin Endocrinol Metab. 1998 Mar;83(3):807-13. doi: 10.1210/jcem.83.3.4674.